fluorodopa f 18 has been researched along with MEA 2a in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chabrier, G; Imperiale, A; Rotania, M | 1 |
Dollé, F; Ducongé, F; Gombert, K; Kuhnast, B; Le Helleix, S; Pestourie, C; Tavitian, B; Thézé, B | 1 |
2 other study(ies) available for fluorodopa f 18 and MEA 2a
Article | Year |
---|---|
Synchronous bilateral pheochromocytomas and bilobar medullary thyroid carcinoma revealed by
Topics: Adrenal Gland Neoplasms; Adult; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Female; Humans; Multiple Endocrine Neoplasia Type 2a; Pheochromocytoma; Positron Emission Tomography Computed Tomography; Thyroid Neoplasms | 2019 |
PET imaging of medullary thyroid carcinoma in MEN2A transgenic mice using 6-[(18)F]F-L-DOPA.
Topics: Animals; Carcinoma, Medullary; Dihydroxyphenylalanine; Mice; Mice, Transgenic; Multiple Endocrine Neoplasia Type 2a; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms | 2010 |